Al-Charrakh Alaa H
Department of Microbiology, College of medicine, Babylon University, Iraq.
J Infect Dev Ctries. 2012 Jun 15;6(6):489-94. doi: 10.3855/jidc.1817.
The presence of microorganisms in pharmaceuticals is undesirable because they may cause spoilage of the product and may present an infection hazard to the consumers or patients.
A total of 102 samples of oral and topical non-sterile pharmaceutical products were collected at random from different drug houses and pharmacies in Iraq, to investigate the microbial contamination of these products. Bacterial isolates recovered from these medicaments were subjected to susceptibility testing against various antibiotics by disk diffusion method according to Clinical and Laboratory Standards (CLSI) guidelines.
The results revealed that the occurrence of gram-positive bacteria was in oral and topical medicaments while gram-negative bacteria were only detected in topical medicaments. More than 58% of Bacillus isolates were resistant to lincomycin and Bacillus mycoides isolates were resistant to beta-lactam antibiotics and trimethoprim-sulfamethoxazole. Staphylococcus spp. showed a relatively high resistance to ampicillin, amoxicillin, penicillin, tetracycline, and trimethoprim-sulfamethoxazole. S. epidermidis had the highest number of multi-resistant isolates. Furthermore, 87.5% of isolated gram-negative rods showed high resistance to beta-lactam antibiotics and 75% of them were highly resistant to erythromycin. One isolate of Pseudomonas aeruginosa was the most resistant among all gram-negative rod isolates.
The high rate of resistance to antimicrobial agents of bacterial isolates recovered from oral and topical medicaments in this study may indicate a widespread antibiotic resistance among bacteria isolated from different sources, including those of anthropological and environmental origin.
药品中存在微生物是不可取的,因为它们可能导致产品变质,并可能对消费者或患者构成感染风险。
从伊拉克不同的药店和药房随机收集了102份口服和外用非无菌药品样本,以调查这些产品的微生物污染情况。根据临床和实验室标准(CLSI)指南,采用纸片扩散法对从这些药物中分离出的细菌菌株进行了多种抗生素的药敏试验。
结果显示,革兰氏阳性菌存在于口服和外用药物中,而革兰氏阴性菌仅在外用药物中检测到。超过58%的芽孢杆菌菌株对林可霉素耐药,蕈状芽孢杆菌菌株对β-内酰胺类抗生素和甲氧苄啶-磺胺甲恶唑耐药。葡萄球菌属对氨苄西林、阿莫西林、青霉素、四环素和甲氧苄啶-磺胺甲恶唑表现出较高的耐药性。表皮葡萄球菌的多重耐药菌株数量最多。此外,87.5%的分离革兰氏阴性杆菌对β-内酰胺类抗生素表现出高度耐药性,其中75%对红霉素高度耐药。一株铜绿假单胞菌在所有革兰氏阴性杆菌分离株中耐药性最强。
本研究中从口服和外用药物中分离出的细菌菌株对抗菌剂的高耐药率可能表明从不同来源分离出的细菌中存在广泛的抗生素耐药性,包括来自人类和环境来源的细菌。